[HTML][HTML] Blockade of phosphotyrosine pathways suggesting SH2 superbinder as a novel therapy for pulmonary fibrosis
M Wang, AD Liu, Q Niu, X Feng, YY Zheng, SJ Chen… - Theranostics, 2022 - ncbi.nlm.nih.gov
Background: Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible fibrotic
disease with high mortality. Currently, pirfenidone and nintedanib are the only approved …
disease with high mortality. Currently, pirfenidone and nintedanib are the only approved …
Recent developments of nanomedicine delivery systems for the treatment of pancreatic cancer
Pancreatic cancer (PCa) is one of the principal causes of death from cancer, resulting in a
low patient survival rate due to its late diagnosis. Many factors are involved in the failure of …
low patient survival rate due to its late diagnosis. Many factors are involved in the failure of …